ORAMED PHARMACEUTICALS INC. Accumulated Other Comprehensive Income
ORAMED PHARMACEUTICALS INC. (ORMP) had Accumulated Other Comprehensive Income of $702.00 thousand as of 2018-08-31, per its 10-K filed 2019-11-27.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2019-11-27
- 2018-08-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $702.00K.
- 2018-05-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $198.00K.
- 2018-02-28: Accumulated Other Comprehensive Income (Loss), Net of Tax $313.00K.
- 2017-11-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $727.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2018-08-31 | $702.00K 10-K · filed 2019-11-27 | |
| 2018-05-31 | $198.00K 10-Q · filed 2018-07-12 | |
| 2018-02-28 | $313.00K 10-Q · filed 2018-04-09 | |
| 2017-11-30 | $727.00K 10-Q · filed 2018-01-11 | |
| 2017-08-31 | $401.00K 10-K · filed 2018-11-28 | |
| 2017-05-31 | $497.00K 10-Q · filed 2017-07-06 | |
| 2017-02-28 | $211.00K 10-Q · filed 2017-04-05 | |
| 2016-11-30 | $43.00K 10-Q · filed 2017-01-11 | |
| 2016-08-31 | $106.00K 10-K · filed 2017-11-29 | |
| 2016-05-31 | $314.00K 10-Q · filed 2016-07-06 | |
| 2016-02-29 | $230.00K 10-Q · filed 2016-04-06 | |
| 2015-11-30 | $152.00K 10-Q · filed 2016-01-13 | |
| 2015-08-31 | $558.00K 10-K · filed 2016-11-25 | |
| 2015-05-31 | $163.00K 10-Q · filed 2015-07-01 | |
| 2015-02-28 | $100.00K 10-Q · filed 2015-04-03 | |
| 2014-11-30 | $93.00K 10-Q · filed 2015-01-08 | |
| 2014-08-31 | $452.00K 10-K · filed 2015-11-25 | |
| 2014-05-31 | $467.97K 10-Q · filed 2014-07-14 | |
| 2014-02-28 | $846.99K 10-Q · filed 2014-04-10 | |
| 2013-11-30 | $334.17K 10-Q · filed 2014-01-14 | |
| 2013-08-31 | $304.00K 10-K · filed 2014-11-14 | $303.40K 10-K · filed 2013-11-27 |
| 2013-05-31 | $131.92K 10-Q · filed 2013-07-17 | |
| 2013-02-28 | $244.51K 10-Q · filed 2013-04-11 | |
| 2012-11-30 | $235.87K 10-Q · filed 2012-12-26 | |
| 2012-05-31 | $15.87K 10-Q · filed 2012-07-12 | |
| 2011-11-30 | -$4.22K 10-Q · filed 2012-01-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |